Singapore pharma firm debuts on Korean main bourse

The firm develops biosimilars, new antibody therapeutics.

Singapore-based biopharmaceutical company Prestige BioPharma has become the first Singapore company to be listed on the Korea Exchange (KOSPI).

The firm focuses on developing biosimilars and new antibody therapeutics.

According to reports, Prestige BioPharma has debuted on the KOSPI due to its business relations with Prestige Biologics, a biologics contract development manufacturing organisation that would manufacture the firm’s core products and has facilities in Korea.

“Our listing is an important inflexion point for Prestige BioPharma as we now have ample resources to pursue our expansion plans in the global biopharmaceutical market, “ CEO Lisa Park said. “With our biosimilar and antibody drugs in the pipeline, we are very excited about our growth prospects.”

The firm’s initial public offering of 15,341,640 DR, at $38.2 (₩32,000) a share received strong demand from investors, with the public offer trance of 20% being about 237 times oversubscribed.

Meanwhile, the placement tranche of 12.3 million DR was approximately 800 times oversubscribed, the firm said.

The counter closed at $50.8 (₩42,600) on its second day of trading on 8 February, a premium of about 33% over its IPO price.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia